Vascutek, Ltd. Recalls Gelsoft Plus and Gelweave Vascular Devices Due to Incorrect Shelf Life Labeling
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Vascutek, Ltd. is recalling over 37,000 Gelsoft Plus and Gelweave vascular prostheses because they were labeled with an incorrect expiration date, extending the shelf life by one month.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Vascutek, Ltd. has initiated a voluntary recall of gelatin-sealed woven polyester prostheses used for vascular repair. The devices were incorrectly labeled with an additional month of shelf life. According to the manufacturer, the device expiry should have been calculated from the date of gel impregnation (the date of manufacture); however, it was incorrectly calculated from the date of device packaging.
Which Products Are Affected
This recall affects approximately 37,430 units distributed nationwide across the United States. Affected products include various models of the following brands:
- Gelsoft Plus: Includes any item number ending in 'E-B' (e.g., 631206PE-B). Specific REF numbers include 635024PE, 631514PE, 631222PE, 633008PE, 633010PE, 633007PE, 636010PE, 632522PE, 633012PE, 635018PE, and others listed in the official recall notice.
- Gelweave: Includes any item number ending in 'E-B' (e.g., 7320128/10RMEE-B). Specific REF numbers include 736038E, 736036E, 736034E, 736032ST/10DE, 736032E, 736030ST/10DE, 736030E, 736028ST/10DE, 736028E, and many others.
Recall Number: Z-1492-2026
Distribution Scope: Nationwide distribution including FL, PA, TX, NC, NY, CA, NJ, OH, MI, DC, CO, VA, GA, IL, OR, ND, VT, MS, MA, IN, WA, AZ, MN, MD, IA, OK, MO, AL, WI, LA, AR, TN, CT, ME, NE, SC, KS, NV, KY, RI, WV, UT, MT, ID, AK, NH, DE, NM, SD, HI, and WY.
What You Should Do
Vascutek, Ltd. initiated the recall by sending notification letters to affected customers. Healthcare providers and facilities should immediately review their inventory for the affected REF and item numbers. If you have these products in stock, follow the specific instructions provided in the manufacturer's letter regarding the return or disposal of the devices.
Why This Matters
The significance of this recall lies in the potential for devices to be used beyond their validated stability period. Incorrect shelf life labeling can lead to the use of prostheses that may not perform as intended during critical vascular repair procedures.
Source
FDA - Recall Event ID: 98338
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.